The 2020 GU XIAOCHENG LECTURE is awarded to Dr. Bo Zhong of Wuhan University.

The Gu Xiaocheng lecture award was established by the Gu Xiaocheng Memorial Fund in 2012. The lectureship recognizes young investigators showing promises to become future leaders in life science research, especially those who work in China.

Dr. Bo Zhong received his Ph.D. from School of Life Sciences, Wuhan University, China in 2010. He did postdoctoral research in MD Anderson Cancer Center, University of Texas, (2010-2013) in USA. Under the National 1000 Young Talents Program, Dr. Zhong joined the faculty of School of Life Sciences, Wuhan University, in 2013. He is currently an adjunct professor of Medical Research Institute and a member of the Frontier Science Center for Immunology and Metabolism, Wuhan University.

Dr. Zhong has been working on the regulatory mechanisms of antiviral immunity for a few years. Meanwhile, he extends his research interest to infection-related inflammation and tumorigenesis and hopes that his discoveries can provide new strategies for targeted therapies of the related diseases. His group has characterized critical roles of USP25 and USP2a in the development of colitis and colorectal cancer and tumor metastasis and provided evidence that targeting USP25 and USP2a effectively inhibits bacterial infections, tumorigenesis and metastasis.

Dr. Zhong is praised by his peers as a potential leader in biomedical research, especially in the field of infectious immunity and tumorigenesis in the next few years. He is open-minded and always ready to help others. He provides materials and animals to others without hesitation and provides his expertise and constructive suggestions to his colleagues’ research.

顾孝诚教授介绍

顾孝诚（1930年2月13日－2012年11月3日），北京大学生命科学学院教授，曾任北京大学生物学系主任，“国家高技术研究发展发计划（863计划）”生物技术领域专家组成员及蛋白质工程评审专家组组长，教育部中美联合招收生物化学与分子生物学博士研究生项目（CUSBEA）中方协调员。领导并参与筹建了北京大学蛋白质工程及植物基因工程国家重点实验室、生物膜与膜生物工程国家重点实验室、北京大学生物信息中心、北京大学分子医学研究所、北京大学药物信息与工程研究中心等现代生物技术研究机构。